1 / 74

Inflammation Chronic inflammation and aging Why? Inflammation, immune activation and HIV infection

Role of inflammation in the pathogenesis of age-related comorbidities Jacqueline Capeau INSERM U938, Université Pierre et Marie Curie Faculté de Médecine, site Saint-Antoine, H ôpital Tenon, Paris, France. Inflammation Chronic inflammation and aging Why?

ura
Download Presentation

Inflammation Chronic inflammation and aging Why? Inflammation, immune activation and HIV infection

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Role of inflammation in the pathogenesis of age-related comorbiditiesJacqueline CapeauINSERM U938, Université Pierre et Marie Curie Faculté de Médecine, site Saint-Antoine, Hôpital Tenon, Paris, France

  2. Inflammation Chronic inflammation and aging Why? Inflammation, immune activation and HIV infection Consequences on morbidity/mortality in HIV-infected patients Anti-inflammatory treatment: Statins?

  3. Acute inflammation « Rubor et tumor cum calore et dolore » Redness and swelling with heat and pain Corneluis Celsius 1rst century AD

  4. Inflammation pathways components Infection Injury Host defense Tissue repair Inflammation R Medzhitov Cell 2010

  5. Inflammation and the stress response R Medzhitov Cell 2010

  6. Inflammation Chronic inflammation and aging Why? Inflammation, immune activation and HIV infection Consequences on morbidity/mortality in HIV-infected patients Anti-inflammatory treatment: Statins?

  7. Chronic low-grade inflammation is associated with most age-related diseases Hs-CRP< 10mg/l Hs-IL6 A Freund Trends Molecular Med 2010

  8. X Chronic low-grade inflammation Not caused by classicinducers: infection and injury Due to tissue stress and malfunction?

  9. « Inflammaging » « Immune activation  » Proinflammatory cytokines produced by immune cells: monocytes/macrophages and T lymphocytes but also endothelial cells, adipocytes, epithelial cells HY Chung Aging Research Reviews 2008,9;8:18

  10. Implication of inflammation in aging processes Salminen Cell Signal 2010

  11. Inflammation Chronic inflammation and aging Why? Inflammation, immune activation and HIV infection Consequences on morbidity/mortality in HIV-infected patients Anti-inflammatory treatment: Statins?

  12. Gut-derived inflammation and metabolicrisk

  13. Intestinal Microbiota 1014 bacteria and archaea Large diversity: 1100species 150 more gene than our own genome From Burcelin London 2010

  14. Role of food composition in systemic inflammation and metabolic consequences sCD14 M Serino Diabetes Metab 2009

  15. Role of adipose tissue in inflammaging GUT LPS, sCD14 From VD Dixit J Leukoc Biol 2008

  16. Inflammation, immune activation And cardio-vascularrisk

  17. Initiation of atherosclerosis : activation of macrophages AM LundbergClinicalImmunology 2010

  18. Role of innate and acquired immunity in atherosclerosis progression TLR stimulation of macrophages results in the release of proinflammatory cytokines, TNFa, IL-1 and IL-6, that can have both local and systemic effects. AM LundbergClinicalImmunology2010

  19. Role of immune activation in plaque inflammation and risk of rupture and thrombosis J Andersson ClinicalImmunology 2010

  20. Increased levels of CRP and LDL-c decrease the probability of cardiovascular event-free survival EY Yang J Am CollCardiology 2009

  21. Role of personal and life-style factors

  22. Inflammation Chronic inflammation and aging Why? Inflammation, immune activation and HIV infection Consequences on morbidity/mortality in HIV-infected patients Anti-inflammatory treatment: Statins?

  23. Early occurrence of age-related comorbidities Osteoporosis Neurocognitive dysfunction Sarcopenia Frailty Cardio-vascular risk and hypertension Fat redistribution and lipodystrophy Insulin resistance, diabetes et dyslipidemia Non-AIDS related Cancers HIV-infected patients Premature aging

  24. Non-AIDS defining comorbidities HIV- HIV+ INCIDENCE 10-15years AGE From J Campisi

  25. Increased levels of proinflammatory and prothrombotic markers in HIV-infected patients as compared to the general population J Neuhaus CID 2010

  26. Why ? HIV- HIV+ Inflammation, Immune Activation, thromboticrisk HIV, ART Immune depletion/senescence INCIDENCE AGE 10-15 years From J Campisi

  27. Inflammaging in HIV-infected patients Virus Role of chronic infection Role of treatment Role of inflammation/immune activation Role of immune deficiency/senescence Role des personal factors : age, tobacco, coinfections Earlyaging Immunity ART

  28. Virus and inflammation

  29. p=0.0408 p=ns CV copies/mL IL6 <0.685 IL6 >0.685 CRPUS <1 CRPUS: 1-3 CRPUS >3 The level of IL-6 is related to viral load in HIV-infected patients with a controlled VL • 122 patients, ART-treated, VL: 1 to 500 copies/ml, • IL-6 values were positively related to HIV-RNA levels (rho=0.217 p=0.017) JP Bastard Workshop Adverse Drug ReactionComorbidities London 2010

  30. ART and inflammation

  31. Effect of different antiretrovirals on human adipocytes : PI and NRTI C Lagathu Antiviral Ther 2007

  32. Some PI induce oxidative stress and inflammation in endothelial cells: Beneficial effect of statins Lefèvre ATVB 2010

  33. Chronic immune activation and inflammation HIV Infection and replication Anti-HIVimmunity Reactivation of otherviruses Intestinal bacterial translocation Production of viral proteins Immune activation: Acquired and InnateImmunity Lymphocytes T Differentiation and senescence Proinflammatory cytokines secretion Chronic inflammation Immune depletion and immune senescence Non-AIDSdefiningmorbidity and mortality D’après V Appay J Pathol 2008

  34. Relations between bacterial translocation, immune activation and chronic inflammation  Bacterial translocation in naïve and treated patients LPS, 16S rDNA sCD14, innateimmunity activation IL-6 acquiredimmunity activation, CD4, CD8 CRP immune depletion/senescence JM Brenchley Nat Med 2006 W Jiang JID 2009 R Rajasuriar JID 2010

  35. Inflammation Chronic inflammation and aging Why? Inflammation, immune activation and HIV infection Consequences on morbidity/mortality in HIV-infected patients Anti-inflammatory treatment: Statins?

  36. Roleof immune activation and inflammation in non-AIDS-defining mortality

  37. Fibrinogen and CRP are independent risk factors for mortality in the FRAM study Even in patients with preserved CD4 count >500 cells per microliter, inflammation remains an important factor for mortality P Tien JAIDS 2010

  38. NG Sandler CID 2011

  39. Relations between bacterial translocation, immune activation and cardio-vascular risk  Bacterial translocation naïve and treated patients LPS, 16S rDNA sCD14, innateimmunity activation IL-6 acquiredimmunityactivation, CD4, CD8 CRP immune depletion/senescence JM Brenchley Nat Med 2006 W Jiang JID 2009 Cardio-vascularrisk R Rajasuriar JID 2010 RC Kaplan Atherosclerosis, CID 2011

  40. RC Kaplan CID 2011

  41. IMT is associated with CRP and insulin resistance AC Ross CID 2009

  42. Role of bacterial translocation and immune activation In neurocognitive disorders

  43. 179 subjects, median age 48 years, • 14 (8%) patients with neuropsychological deficit (ND), 22 (12%) with asymptomatic neurocognitive impairment (ANI), 14 (8%) with mild cognitive impairment (MCD), and 5 (3%) with HIV-associated dementia (HAD) : 31% affected. • Mean LPS values for NT were 94±47 pg/mL, ND: 131±37 pg/mL, ANI: 122±61 pg/mL, MCD: 131±8 pg/mL, HAD: 129±45 pg/mL (p = 0.002). • In multivariate analysis, plasma LPS >120 pg/mL (p = 0.0001) and pDNA (p = 0.032) were independent risk factors for NI. Plasma LPS increasedeven in mildforms of impairment, whethersymptomatic or not H Carsenti-Dellamonica CROI 404

  44. J Lyons CROI 2011 # 405

  45. Lipodystrophy worseninflammatory state and metabolicdisorders

  46. Lipodystrophic HIV-infected patients have increased CRP and decreased adiponectin levels K Samaras Obesity 2009

  47. Lipodystrophy and ART predict atherosclerosis lesions in HIV-infected patients Multivariable logistic analysis for independent predictors of coronary artery calcium G Guaraldi Atherosclerosis 2010

  48. The inflammatory status 48 weeks after cART initiation is associated with an increased incidence of diabetes TT Brown Diabetes Care 2010

  49. TL Stanley AIDS 2011

More Related